middle.news
Island Pharmaceuticals Nears Key Milestone in Dengue Trial, Boosts Cash by $1.94m
5:29am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Island Pharmaceuticals Nears Key Milestone in Dengue Trial, Boosts Cash by $1.94m
5:29am on Monday 2nd of June, 2025 AEST
Key Points
Phase 2b dosing completed with target blood levels achieved
Top-line efficacy data for Phase 2a/b cohorts due by end of May 2025
Raised $1.94 million from exercise of listed options
Advancing acquisition talks for broad-spectrum antiviral Galidesivir
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
ISLAND PHARMACEUTICALS (ASX:ILA)
OPEN ARTICLE